Research on Pharmacotherapy for Neuropathic Pain
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 64
Special Issue Editor
Interests: neuropathic; nociceptive; central sensitization pain; post-operative pain; headache; spinal pain; other non-specific pain; pain management; animal study; clinical study; drug delivery; pain intervention
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuropathic pain is generally defined as pain resulting from nerve damage or dysfunction of the somatosensory system and can present in the form of hyperalgesia, allodynia, and paroxysmal or spontaneous pain, which are ordinarily intractable. The obvious pathophysiology of neuropathic pain has not yet been fully understood, but various studies have proposed several consistent pathophysiological mechanisms that are related to neurogenic inflammatory responses and central sensitization. Therefore, multimodal analgesia is the currently recommended strategy for neuropathic pain management. However, due to the diversity of mechanisms, neuropathic pain is sometimes difficult to treat. In order to treat neuropathic pain, pharmacotherapy is still challenging and plays a key role.
We are pleased to invite you to contribute to this Special Issue, titled “Research on Pharmacotherapy for Neuropathic Pain”. This Special Issue aims to introduce and highlight all pharmacological treatments for neuropathic pain including biopharmaceutics, biomedical sciences, cell biology, interdisciplinary research, study of alternative targets or novel therapeutic strategies, new pharmaceutical formulations and drug delivery systems as well as drug repositioning approaches, etc., through animal and clinical study.
In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Hue Jung Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuropathic
- pain
- peripheral
- spinal
- central
- sensitization
- pain management
- animal study
- clinical study
- drug delivery
